World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
33907
World Ranking
10452
National Ranking
141

Overview

Davide Rossi is affiliated with the European Society for Medical Oncology in Switzerland and has a research focus within the field of Medicine, with a significant number of publications related to Pathology and Forensic Medicine, Genetics, Oncology, Immunology, and Cancer Research. Their scientific contributions are notably concentrated on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics, Immunodeficiency and Autoimmune Disorders, Genetic Factors in Colorectal Cancer, Viral-associated Cancers and Disorders, and CAR-T Cell Therapy Research.

Rossi has published extensively in prominent venues, with a concentrated output in the following journals:

  • Blood
  • Hematological Oncology
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia

Their recent papers demonstrate ongoing engagement with detailed molecular and clinical aspects of hematological cancers and related fields. These include:

  • Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA, 2021, Nature Biotechnology
  • COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus, 2020, Leukemia
  • Genomic profiling for clinical decision making in lymphoid neoplasms, 2022, Blood
  • International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia, 2020, Blood
  • Detection of early seeding of Richter transformation in chronic lymphocytic leukemia, 2022, Nature Medicine

Frequent collaborators include researchers active in hematology and oncology fields, with key coauthors being:

  • Gianluca Gaïdano
  • Emanuele Zucca
  • Francesco Bertoni
  • Riccardo Moia
  • Valter Gattei

Rossi's body of work reflects a detailed involvement in clinical and genomic aspects of lymphoid neoplasms and related disorders. Their publication record includes important contributions to diagnostics and prognostic tools for chronic lymphocytic leukemia, as well as studies addressing complications such as Richter transformation.

They contribute actively to scientific discussions at the interface of clinical hematology, molecular genetics, and cancer research, with an emphasis on integrating genomic profiling into clinical decision-making processes. Their research also engages with the impact of infectious diseases, such as COVID-19, on hematological conditions, illustrating a breadth in translational and clinical research within oncology.

Best Publications

  • Analysis of the coding genome of diffuse large B-cell lymphoma

    Laura Pasqualucci;Vladimir Trifonov;Giulia Fabbri;Jing Ma

  • Inactivating mutations of acetyltransferase genes in B-cell lymphoma

    Laura Pasqualucci;David Dominguez-Sola;Annalisa Chiarenza;Giulia Fabbri

  • Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

    Giulia Fabbri;Silvia Rasi;Davide Rossi;Vladimir A. Trifonov

  • Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Valeria Spina;Alessio Bruscaggin

  • Genetics of Follicular Lymphoma Transformation

    Laura Pasqualucci;Hossein Khiabanian;Marco Fangazio;Mansi Vasishtha

  • Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

    Antonio Palumbo;Sara Bringhen;Davide Rossi;Maide Cavalli

  • Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Giulia Fabbri;Valeria Spina

  • Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

    Sara Bringhen;Alessandra Larocca;Davide Rossi;Maide Cavalli

  • Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

    Davide Rossi;Alessio Bruscaggin;Valeria Spina;Silvia Rasi

  • Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

    Ramona Crescenzo;Ramona Crescenzo;Francesco Abate;Francesco Abate;Francesco Abate;Elena Lasorsa;Fabrizio Tabbo;Fabrizio Tabbo

  • The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

    Davide Rossi;Valeria Spina;Clara Deambrogi;Silvia Rasi

  • The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development

    Davide Rossi;Vladimir Trifonov;Marco Fangazio;Alessio Bruscaggin

  • Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

    Davide Rossi;Hossein Khiabanian;Valeria Spina;Carmela Ciardullo

  • The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

    Davide Rossi;Michaela Cerri;Clara Deambrogi;Elisa Sozzi

  • Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

    Davide Rossi;Marco Fangazio;Silvia Rasi;Tiziana Vaisitti

  • Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

    David M. Kurtz;Florian Scherer;Florian Scherer;Michael C. Jin;Joanne Soo

  • Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

    Antonio Palumbo;Michele Cavo;Sara Bringhen;Elena Zamagni

  • Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

    P Baliakas;A Hadzidimitriou;L-A Sutton;D Rossi

  • Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

    Manel Esteller;Manel Esteller;Gianluca Gaidano;Steven N. Goodman;Vittorina Zagonel

  • Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

    E. Tiacci;J. H. Park;L. De Carolis;S. S. Chung

Frequent Co-Authors

Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Valter Gattei
Valter Gattei University of Trieste
Francesco Bertoni
Francesco Bertoni Institute of Oncology Research
Daniela Capello
Daniela Capello University of Eastern Piedmont Amadeo Avogadro
Luca Laurenti
Luca Laurenti Catholic University of the Sacred Heart
Robin Foà
Robin Foà Sapienza University of Rome
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Silvia Deaglio
Silvia Deaglio University of Turin
Francesca Rossi
Francesca Rossi University of Campania "Luigi Vanvitelli"
Francesco Di Raimondo
Francesco Di Raimondo University of Catania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees and career pathways can open up additional opportunities in the healthcare field beyond a traditional MD. For those interested in beginning their careers quickly, a lpn accelerated program allows you to qualify as a Licensed Practical Nurse in less time, often through flexible online classes.

For nursing professionals seeking to specialize in mental health, online pmhnp programs offer a convenient route to becoming a Psychiatric Mental Health Nurse Practitioner. These programs are designed to accommodate busy schedules while preparing graduates for advanced practice roles.

Prefer to work on the administrative side of healthcare? Consider enrolling in the cheapest online healthcare administration degree programs, which provide vital management skills for a fraction of the cost. If you are interested in advancing further, cheap mha programs deliver valuable master's-level training suited for leadership roles within hospitals and health organizations.

These online degree options offer flexibility, affordability, and the chance to pursue a rewarding healthcare career tailored to your unique interests and goals.

Best Scientists Citing Davide Rossi

Trending Scientists

Recently Published Articles